On 27 June, FRIB hosted Professor Dr. Richard Baum of the Theranostics Center for Molecular Radiotherapy and Molecular Imaging, Zentralklinik Bad Berka, in Germany. Professor Dr. Baum spent the day at Michigan State University (MSU) meeting MSU faculty members and Michigan business leaders. FRIB Deputy Laboratory Director Paul Mantica met with Professor Dr. Baum and provided a tour of the FRIB Laboratory.

Professor Dr. Baum and his team specialize in Peptide Receptor Radionuclide Therapy, an internal molecular therapy using radioactive material to treat neuroendocrine tumors in patients. He has been the chairman and clinical director of the Theranostics Center for Molecular Radiotherapy and Molecular Imaging since 1997 and professor of nuclear medicine at the Goethe University of Frankfurt since 1996.